Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2021

Deferred revenue consisted of the following:


	March 31, 2021		December 31, 2020
Deferred extended maintenance and support	$	2,757	$	2,902
Deferred royalties	280		282
Deferred device and advances	100		118
Total deferred revenues	3,137		3,302
Less current portion	(1,493)		(1,496)
Deferred revenues, non-current	$	1,644	$	1,806

Deferred revenue activity consisted of the following for the three months ended March 31, 2021:



Beginning balance	$	3,302
Deferral of revenue	289
Recognition of deferred revenue	(454)
Ending balance	$	3,137

The following table disaggregates the Company’s revenue by major source for the three months ended March 31, 2021:


	EksoHealth		EksoWorks		Total
Device revenue	$	1,019	$	98	$	1,117
Service and support	488		—		488
Rentals and subscriptions	152		70		222
Parts and other	54		15		69
Collaborative arrangements	14		—		14
	$	1,727	$	183	$	1,910

The following table disaggregates the Company’s revenue by major source for the three months ended March 31, 2020:


	EksoHealth		EksoWorks		Total
Device revenue	$	306	$	255	$	561
Service and support	469		—		469
Rentals	194		—		194
Parts and other	155		22		177
Collaborative arrangements	67		—		67
	$	1,191	$	277	$	1,468